GlaxoSmithKline choose DAML+OIL

From: Ian Horrocks (
Date: 06/08/01

Dear All

I thought you would be interested to know that as part of their
corporate knowledge management strategy GlaxoSmithKline
Pharmaceuticals have commissioned a new gene ontology the
specification for which explicitly states that it must be delivered in
DAML+OIL. This is just the latest indicator of the major impact that
DAML+OIL is having in the bio-informatics arena.

Regards, Ian

This archive was generated by hypermail 2.1.4 : 04/02/02 EST